论文部分内容阅读
目的:探讨培菲康联合肠炎宁糖浆在急性肠炎患者中的临床疗效。方法:将我院收治的急性肠炎患者80例随机分为对照组和观察组,分别采用肠炎宁糖浆和培菲康联合肠炎宁糖浆进行治疗,观察两组患者的临床治疗效果。结果:两组在不良反应发生率上差异不大,但观察组治疗有效率(95.0%)高于对照组(77.5%),各项症状改善时间短于对照组,差异明显具有统计学意义(P<0.05)。结论:对于急性肠炎患者而言,培菲康和肠炎宁糖浆联合治疗的临床疗效更佳,能够促进各项症状的恢复,不良反应发生较少,值得临床推广。
Objective: To investigate the clinical efficacy of combination of Beifenfei and Jiayanning syrup in patients with acute enteritis. Methods: Eighty patients with acute enteritis admitted to our hospital were randomly divided into control group and observation group. The patients were treated with enteric-syrup and Peifenkang combined with Changyinning syrup respectively. The clinical effect of the two groups was observed. Results: There was no significant difference in the incidence of adverse reactions between the two groups, but the effective rate (95.0%) in the observation group was significantly higher than that in the control group (77.5%), and the improvement time of each symptom was shorter than that in the control group P <0.05). Conclusion: For patients with acute enteritis, the combination of Peifei Kang and Jiayanning syrup has better clinical curative effect, which can promote the recovery of various symptoms with fewer adverse reactions and is worthy of clinical promotion.